ArticleHaematologica2012

Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes.

Sheila Weiss Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.